Merck KGaA 1 avr. 2026 Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business - Merck Group
FierceBiotech 25 mars 2026 Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition
Endpoints News 25 mars 2026 Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis' Scemblix
Endpoints News 24 mars 2026 Merck partners with Flagship startup Quotient to search for genetic clues to IBD
FierceBiotech 6 mars 2026 Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal
BioPharma Dive 12 févr. 2026 Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo